Real-World Outcomes of Proprotein Convertase Subtilisin Kexin-9 Inhibitor Use : Journal of Cardiovascular Pharmacology

Journal Logo

Original Article

Real-World Outcomes of Proprotein Convertase Subtilisin Kexin-9 Inhibitor Use

Kim, Olivia M. PharmD*; Givens, Tatyana K. PharmD†,‡; Tang, Emily G. PharmD§,¶; Schimmer, Jennifer J. PharmD§; Ramsey, Tanya PharmD*; Boyd, Kayla PharmD; Delate, Thomas PhD, MS¦

Author Information
Journal of Cardiovascular Pharmacology 81(5):p 339-347, May 2023. | DOI: 10.1097/FJC.0000000000001404

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid